I’m going to invest my children’s education in the CVR

Discussion in 'Bristol-Myers Squibb' started by anonymous, Nov 17, 2020 at 7:05 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    It’s at $0.80 a share and I have $30K saved for my kids.

    If I invest it all in the CVRs and both drugs are approved I’ll have almost $350K saved for college.

    Who else is with me? There’s no way our leadership fails!
     

  2. anonymous

    anonymous Guest

    Isn’t the inspection scheduled?
     
  3. anonymous

    anonymous Guest

    thats a big dick energy move.
     
  4. anonymous

    anonymous Guest

    There is a reason that they dropped from 3.40 to .80 in just a few days! Be careful
     
  5. anonymous

    anonymous Guest

     
  6. anonymous

    anonymous Guest

    Going back up. Inspection of plant in Texas rescheduled?
     
  7. anonymous

    anonymous Guest

    For what it’s worth, there are rumors swirling that inspectors are inspecting Texas Lonza. This is both unconfirmed and second hand info.
     
  8. anonymous

    anonymous Guest

    Not true!
     
  9. anonymous

    anonymous Guest

    Not true about rumors or about the inspection taking place to get timely approval?
    Wouldn’t let employees know.
    Call Texas plant...
     
  10. anonymous

    anonymous Guest

    Told you
     
  11. anonymous

    anonymous Guest

    Virtual inspection? Approval in the works.
     
  12. anonymous

    anonymous Guest

  13. anonymous

    anonymous Guest

    It’s almost certain this is approved quickly. Why wouldn’t it be?
     
  14. anonymous

    anonymous Guest

    I can give you 9 billion reasons why...
     
  15. anonymous

    anonymous Guest

    Question guys. Apologies if this go a basic question. What I don’t understand with the CVR is if the payout is $9, why does it trade only at $1.80? I think the payment date is only a few months away so I was expecting the price to be higher. What am I missing. Thank you!
     
  16. anonymous

    anonymous Guest

    From Seeking Alpha OPINION:
    I think the CVR is very attractive at ~$2.40. If I estimate where it will trade based on coming headlines and news, it seems that the CVR can double from here after Liso-cell approval easily. But there also will have something like 80% upside after Liso-cell has been approved. It will go down massively if the end of year deadline is missed. But it likely won't go to zero because of litigation/settlement value. How much litigation value depends on how the deadline gets missed.

    My ignorant question is CAN anyone buy into this if they accept the risk? Or is this only for Celegene stockholders of previous date?
     
  17. anonymous

    anonymous Guest

    It is publicly traded. Anyone can buy. BMY rt

    BMY very tight on withholding any updates. They should keep investors updated on inspection and steps toward approval or say it’s over. This may be a reason for a lawsuit if they have had conversation with fda without disclosure.
     
  18. anonymous

    anonymous Guest

    Run Forrest, Run!
     
  19. anonymous

    anonymous Guest

    Who thinks this gets done by 12/31?